Retatrutide 20mg

Retatrutide is a synthetic triple agonist targeting the GIP, GLP-1, and glucagon receptors simultaneously — the broadest receptor engagement profile of any compound currently in this research class. This triple-pathway mechanism has made it one of the most closely watched compounds in metabolic and body composition research, with study interest spanning energy expenditure, appetite regulation, and lipid metabolism. This listing is for the 20mg concentration.

Every batch is independently third-party tested for HPLC purity (≥99%). Molecular mass and bacterial endotoxin screening performed when possible. This batch (CSX-RT20-0626) tested at 99.94% purity — full results are published on our Lab Results page.

For in-vitro laboratory research use only. Not for human or veterinary use, consumption, injection, or therapeutic application.